ZYBERNO
Stock Report
Updated Aug 31, 2026

electroCore, Inc. (ECOR)

Healthcare • NASDAQ

$9.49

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
electroCore, Inc. (ECOR) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-37.6%)
Return on Capital (Capital Efficiency):CRITICAL (-121.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

electroCore, Inc. (ECOR) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, ECOR generated -$6.87M in Owner Earnings. Capital was deployed as follows: $31.00K invested in capital expenditures. Reinvestment rate: 4.2%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:9.49
Market Cap:$83.50M

Valuation Multiples (2)

P/S Ratio:2.26x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$81.76M

Price Action & Momentum (3)

Momentum Percentile:86 / 100
% of 52-Week High:86.7%
B. Profitability Assessment

Return Metrics (4)

ROA:-81.3%
Reinvestment Rate:4.2%
Fundamental Growth Rate (g):-5.1%

Margin Analysis (3)

Operating Margin Ttm:-37.6%
Net Margin Ttm:-40.0%
Ebitda Margin:-36.3%

TTM Performance (3)

Gross Margin Ttm:87.1%
Operating Margin Ttm:-37.6%
Net Margin Ttm:-40.0%

Yield Metrics (2)

Earnings Yield:-$16.70
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:12.1%
Latest Earnings Filed:2026-08-06

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):48.7%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.21x
Quick Ratio:1.00x
Cash Ratio:0.73x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-15.49x
Times Interest Earned:-15.49

Capital Structure (4)

Working Capital:2,449,000.00
Cash And Cash Equivalents:8,501,000.00
Long Term Debt:$5.77M
Net Debt:-$1.73M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $36.97M
Linear Growth: 48.7%
📊 Click to view full ECOR Revenue analysis & methodology →
Cost Of Revenue Ttm:$4.79M

Profitability Breakdown (2)

Gross profit TTM: $32.18M
Linear Growth: 51.7%
📊 Click to view full ECOR Gross Profit analysis & methodology →
-$13.91M

Bottom Line Performance (3)

-$14.77M
Income Before Tax:-$15.04M
Ebitda Ttm:-13,412,000.00

Operating Expenses (5)

Operating Expenses:46,094,000.00
R And D Expense:3,140,000.00
Sga Expense:42,954,000.00
Income Tax Expense:-$270.00K
Interest Expense:849,100.00

Expense Ratios (3)

R And D To Revenue Percentage:33.2%
Sga To Revenue Percentage:454.5%
Ebitda Margin:-36.3%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$17.06M
Current Assets:$14.12M
Ppe Net:375,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:19,854,000.00
Current Liabilities:11,674,000.00
Long Term Debt:$5.77M
Short Term Debt:$1.00M

Equity & Capital (3)

Equity:-$2.79M
Retained Earnings:-$199.39M
Common Stock:500,000,000.00

Working Capital Items (3)

Accounts Receivable:909,000.00
Inventory:2,418,000.00
Accounts Payable:8,110,000.00

Special Items (2)

Contract Liabilities:153,000.00
Stock Based Compensation:755,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$6.84M-$6.87M

Investment Activities (2)

Investing Cash Flow:$597.00K
Capital Expenditures Ttm:31,000.00

Financing Activities (3)

Financing Cash Flow:$230.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:962,000.00
Long Term Debt Issuance:$7.50M
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.66
-$1.66
Earnings Per Share Ttm:-$1.68

Revenue & Cash Per Share (2)

Sales Per Share Ttm:4.20
Operating Cash Flow Per Share:-$0.93

Book Value & Capital (2)

Book Value Per Share:-$0.32
Cash Per Share:0.97

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:2.04x
Working Capital Turnover Ttm:15.09x

Receivables Management (2)

Receivables Turnover Ttm:40.67x
Days Sales Outstanding Ttm:8.98

Inventory Management (2)

Inventory Turnover Ttm:1.98x
Days Inventory Outstanding Ttm:184.45

Payables & Cash Cycle (2)

Days Payable Outstanding:618.63
Cash Conversion Cycle:-425.21
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$6.87M

Damodaran Growth Analysis (2)

Reinvestment Rate:4.2%
Fundamental Growth Rate (g):-5.1%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):48.7%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):51.7%
Book Value Growth Rate (Linear):-50.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:ECOR
Company Name:electroCore, Inc.
Sector:Healthcare
Industry:Medical Technology
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.80M
Shares Outstanding Basic:9.40K
Shares Outstanding Diluted:9.40K

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 21:20:24 UTC
Data Timestamp:2026-08-19T23:19:45.642079
Scroll to Top